HLB Therapeutics Co.,Ltd.
Develops innovative drugs for rare eye diseases and brain tumors, with vaccine logistics.
115450 | KO
Overview
Corporate Details
- ISIN(s):
- KR7115450009
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 분당구 정자일로 248, 성남시
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
HLB Therapeutics Co., Ltd. is a biopharmaceutical company specializing in the development of innovative, first-in-class drugs for rare and intractable diseases. The company's core focus is on its clinical pipeline, which includes RGN-259, a therapeutic candidate for ophthalmic conditions such as Neurotrophic Keratopathy and Dry Eye Disease, and OKN-007 for treating Glioblastoma Multiforme. In addition to its primary research and development activities, the company has diversified business areas that include vaccine distribution and cold chain logistics.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-28 00:00 |
Share Issue/Capital Change
전환가액의조정
|
Korean | 10.6 KB | ||
| 2025-08-28 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 25.1 KB | ||
| 2025-08-28 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 137.3 KB | ||
| 2025-08-21 00:00 |
Share Issue/Capital Change
전환가액의조정
|
Korean | 11.8 KB | ||
| 2025-08-21 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 137.5 KB | ||
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 1.8 MB | ||
| 2025-07-10 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 136.8 KB | ||
| 2025-07-04 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 141.7 KB | ||
| 2025-07-03 00:00 |
Share Issue/Capital Change
증권발행결과(자율공시)
|
Korean | 5.6 KB | ||
| 2025-07-01 00:00 |
Share Issue/Capital Change
전환가액의조정
|
Korean | 13.1 KB | ||
| 2025-06-20 00:00 |
Capital/Financing Update
주요사항보고서(전환사채권발행결정)
|
Korean | 73.7 KB | ||
| 2025-05-28 00:00 |
Share Issue/Capital Change
전환가액의조정 (제18회차)
|
Korean | 10.2 KB | ||
| 2025-05-28 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 25.1 KB | ||
| 2025-05-28 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 119.0 KB | ||
| 2025-05-21 00:00 |
Share Issue/Capital Change
전환가액의조정 (제17회차)
|
Korean | 11.3 KB |
Automate Your Workflow. Get a real-time feed of all HLB Therapeutics Co.,Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for HLB Therapeutics Co.,Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for HLB Therapeutics Co.,Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
%20Co.%2C%20Ltd/other/SLSBioSpecialty_Lab_Solution_Bio_Co._Ltd-logo.jpg){kind=logo}
